Reply to: correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis”

Michele Gringeria Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

Vera Battinia Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

Gianluca Cammarataa Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

Giulia Mosinia Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

Greta Guarnieria Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

Chiara Leonia Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

Marco Pozzib Scientific Institute, IRCCS E. Medea, Bosisio Parini, LC, ItalyView further author information

Sonia Radicea Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyCorrespondence[email protected]
View further author information

Emilio Clementia Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, Italy;b Scientific Institute, IRCCS E. Medea, Bosisio Parini, LC, ItalyView further author information

Carla Carnovalea Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, ”Luigi Sacco” University Hospital, University of Milan, Milano, ItalyView further author information

show all

References

Mungmunpuntipantip R, Wiwanitkit V. Correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination” Expert Rev Vaccines. 2022;21(8):1–1. DOI: 10.1080/14760584.2022.2070155.
PubMed Web of Science ®Google Scholar
Gringeri M, Battini V, Cammarata G, et al. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. Expert Rev Vaccines. 2022 Feb;25:1–10. Online ahead of print.
Google Scholar
Alatawi YM, Hansen RA. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf. 2017 Jul;16(7):761–767.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Reply to: correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis”

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Reply to: correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis​”

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Reply to: correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis”